Tuesday broker round-up
25th Sep 2018 12:57
(Sharecast News) - Wetherspoons: Peel Hunt downgrades to hold with a target price of 1,325p.
Read moreMonday broker round-up
17th Sep 2018 15:10
(Sharecast News) - Sophos: Deutsche Bank downgrades to hold with a target price of 530p.
Read moreBTG to buy Novate for up to $130m
7th Sep 2018 07:04
(Sharecast News) - Healthcare company BTG on Friday said it was paying up to $130m in cash to buy Ireland-based Novate, which specialises in the prevention of pulmonary embolism (PE) in patients at high risk of venous thromboembolic events.
Read moreBTG's emphysema treatment struck down by FDA
9th Aug 2018 09:04
(Sharecast News) - Global specialist healthcare company BTG on Thursday received confirmation from the US food and drug administration (FDA) that its emphysema treatment will not receive pre-market approval.
Read moreBTG's emphysema treatment struck down by FDA
9th Aug 2018 09:04
(Sharecast News) - Global specialist healthcare company BTG on Thursday received confirmation from the US food and drug administration (FDA) that its emphysema treatment will not receive pre-market approval.
Read moreBTG product gets two ticks of approval
5th Dec 2016 07:08
(ShareCast News) - Global specialist healthcare company BTG announced the inclusion of treatment with its PneumRx Coils product in guidelines for the management of chronic obstructive pulmonary disease on Monday, as published by the Global Initiative for Chronic Obstructive Lung Disease (GOLD). The
Read moreInterventional medicine revenue surges at BTG
15th Nov 2016 07:41
(ShareCast News) - Specialist healthcare company BTG posted its interim results for the six months to 30 September on Tuesday, with double-digit revenue growth underpinned by 24% constant exchange rate growth in interventional medicine revenues. The FTSE 250 firm said its operating profit for the pe
Read moreWednesday broker round-up
26th Oct 2016 17:40
(ShareCast News) - FirstGroup: Goldman Sachs keeps at buy with a target price of 168p. Esure: Berenberg stays at sell, 238p target. Anglo American: Deutsche Bank reiterates hold with a 965p target. Intertek: UBS reiterates buy with a 4100p target. Sainsbury: Goldman Sachs reiterates sell with a 1
Read moreMonday broker round-up
17th Oct 2016 10:15
(ShareCast News) - Coca Cola Hellenic: Jefferies keeps at buy with a target price of 2100p. Jupiter Fund Management: Societe Generale downgrades to hold, 490p target. Aveva: Barclays keeps at equal-weight with a 1450p target. Arrow Global: Numis upgrades to buy with a 405p target. Close Brothers
Read moreFTSE 250 movers: Gold miner Hochschild leads mid-caps lower
6th Oct 2016 15:00
(ShareCast News) - The FTSE 250 retreated further away from its all-time high on Thursday, stung by Brexit worries and investor caution that it may be vulnerable to the reaction to Friday's US non-farm payrolls report. After business group's stressed the importance of immigration to government earli
Read moreBTG lifts revenue guidance on weak sterling
6th Oct 2016 13:45
(ShareCast News) - FTSE 250 specialist healthcare group BTG lifted its revenue guidance for the year on the back of the weak pound. In an update for the six months to 30 September, the company said it now expects reported full-year revenue to be ahead of its previously-announced range of £510m to £5
Read moreFriday broker round-up
15th Jul 2016 15:00
(ShareCast News) - Ashmore: Goldman Sachs upgrades to buy with a target price of 420p and JP Morgan reiterates underweight with a 250p target. G4S: UBS keeps at buy with a 240p target. Essentra: Jefferies reiterates buy with a 715p target. Playtech: UBS stays at buy with a 1000p target. Aberdeen:
Read moreBTG loses out on sterling benefit due to hedging and dollar costs
14th Jul 2016 09:07
(ShareCast News) - Healthcare company BTG said it would make little gains from the collapse of the pound as its currency hedging contracts would negate the potential revenue benefits from the stronger dollar. The FTSE 250 company, in a statement issued ahead of its annual shareholder meeting and aft
Read moreWednesday broker round-up
8th Jun 2016 13:18
(ShareCast News) - Hochschild Mining: UBS downgrades to neutral with a target price of 160p. Esure Group: JP Morgan keeps at overweight with a 330p target. Royal Dutch Shell: RBC reiterates outperform with a target price of 2000p and JP Morgan stays atneutral with a target price of 1630p. National
Read moreRevenue jump boosts BTG full-year profits
17th May 2016 07:56
(ShareCast News) - Healthcare company BTG more than doubled full year pre-tax profits to £57.5m on the back of a 22% jump in revenues to £447.5m. The company said expected revenue for fiscal 2017 to be in the range of £485m-£515m, with selling general and administrative costs to be £160m-£170m and r
Read more